Hims & Hers Health Inc. buy Guggenheim
Start price
28.02.23
/
50%
€11.00
Target price
28.02.24
€14.12
Performance (%)
12.73%
End price
29.02.24
€12.40
Summary
This prediction ended on 29.02.24 with a price of €12.40. The prediction had a final performance of 12.73%. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hims & Hers Health Inc. | 8.373% | 8.373% | -25.010% | 97.692% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% | 48.878% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% | 83.744% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% | 60.392% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% | 61.272% |
Comments by Guggenheim for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $15.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
In the thread Trading Hims & Hers Health Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Guggenheim for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€12.65
27.02.24
27.02.24
€15.66
27.02.25
27.02.25
208.38%
28.02.25
28.02.25
